Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BEAM Beam Therapeutics, Inc.

交易中 01-08 12:11:54 EST

27.98

-0.95

-3.28%

最高28.93	最低27.59	成交量66.07万
今开28.52	昨收28.93	日振幅4.63%
总市值28.39亿	流通市值25.17亿	总股本1.01亿
成交额1,842万	换手率0.73%	流通股本8,994万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BEAM","market":"US","secType":"STK","nameCN":"Beam Therapeutics, Inc.","latestPrice":27.98,"timestamp":1767892314095,"preClose":28.93,"halted":0,"volume":660679,"delay":0,"floatShares":89942800,"shares":101474944,"eps":-4.419301,"marketStatus":"交易中","change":-0.95,"latestTime":"01-08 12:11:54 EST","open":28.52,"high":28.93,"low":27.59,"amount":18424322.899729,"amplitude":0.046319,"askPrice":28.02,"askSize":358,"bidPrice":27.94,"bidSize":278,"shortable":3,"etf":0,"ttmEps":-4.419301,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1767906000000},"marketStatusCode":2,"adr":0,"listingDate":1580965200000,"exchange":"NASDAQ","adjPreClose":28.93,"preHourTrading":{"tag":"盘前","latestPrice":28.55,"preClose":28.93,"latestTime":"09:29 EST","volume":6233,"amount":179766.270883,"timestamp":1767882566014},"postHourTrading":{"tag":"盘后","latestPrice":28.93,"preClose":28.93,"latestTime":"19:59 EST","volume":35117,"amount":1015816.195,"timestamp":1767833952141},"volumeRatio":1.043812,"impliedVol":0.908,"impliedVolPercentile":0.9},"requestUrl":"/m/hq/s/BEAM","defaultTab":"news","newsList":[{"id":"2591022676","title":"Coinbase 将于 12月 16 日 上线 Beam (BEAM) 现货交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2591022676","media":"链捕手","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591022676?lang=zh_cn&edition=full","pubTime":"2025-12-16 09:22","pubTimestamp":1765848170,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，Coinbase Markets 宣布将于 2025 年 12 月 16 日上线 Beam (BEAM) 现货交易，BEAM-USD 交易对将在当日太平洋时间 9:00 之后、流动性条件满足的情况下开放，适用于支持交易的地区。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2229897","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4600","BK4554","BK4556","BK4595","BK4139","BK4516","BK4539","LU1861220207.SGD","BK4585","BEAM","BK4596","BK4611","BK4535","BK4588","LU1861217088.USD","LU2360107671.USD","BK4112","BK4505","LU1861558580.USD","LU1861559042.SGD"],"gpt_icon":0},{"id":"2591623184","title":"Coinbase将上线Beam (BEAM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2591623184","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591623184?lang=zh_cn&edition=full","pubTime":"2025-12-15 16:55","pubTimestamp":1765788900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//flash/324498","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_zh_live","symbols":["BK4588","LU2360107671.USD","BK4505","CONL","BK4595","BK4535","BK4600","BK4516","LU1861220207.SGD","LU1861558580.USD","BEAM","BK4554","LU1861217088.USD","BK4539","COIN","BK4585","BK4596","BK4556","BK4112","BK4551","BK4139","LU1861559042.SGD","BK4611"],"gpt_icon":0},{"id":"1196920972","title":"Beam Therapeutics 更新 Ristoglogene Autogetemcel (Risto-Cel) 的 Beacon 1/2 期临床试验数据，展现镰状细胞病的持久、差异化疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1196920972","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196920972?lang=zh_cn&edition=full","pubTime":"2025-12-06 21:01","pubTimestamp":1765026085,"startTime":"0","endTime":"0","summary":"Beam Therapeutics 更新了 Ristoglogene Autogetemcel (Risto-Cel) 在美国血液学会 (ASH) 年会上关于 Beacon 1/2 期临床试验的数据，强调了其在镰状细胞病 (SCD) 中的持久和差异化疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","BK4556","BK4535","BEAM","BK4585","BK4588","BK4611"],"gpt_icon":0},{"id":"2588732020","title":"Coinbase 将 Beam(BEAM) 列入上币路线图","url":"https://stock-news.laohu8.com/highlight/detail?id=2588732020","media":"链捕手","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588732020?lang=zh_cn&edition=full","pubTime":"2025-12-04 08:17","pubTimestamp":1764807425,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方公告，Coinbase 已将 Beam（BEAM）纳入其上币路线图，后续将视技术与合规审核进展决定具体上线时间。 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2226119","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","LU1861559042.SGD","BK4556","BK4585","BK4595","BK4551","BK4139","BK4505","BK4535","LU2360107671.USD","LU1861220207.SGD","BK4611","BK4600","COIN","BK4516","BK4596","LU1861217088.USD","BK4554","BEAM","BK4588","BK4112","BK4539"],"gpt_icon":0},{"id":"2574383184","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574383184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574383184?lang=zh_cn&edition=full","pubTime":"2025-10-08 22:35","pubTimestamp":1759934140,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日22时35分，Beam Therapeutics Inc.股票出现异动，股价快速上涨5.05%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008223540a4573cd2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008223540a4573cd2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BEAM","BK4611","BK4539","BK4535","LENZ","BK4505","BK4007","BK4139","BK4556","BK4585","BK4588"],"gpt_icon":0},{"id":"1130632456","title":"异动解读 | Beam Therapeutics股价盘中大跌5.08%，Q2财报显示亏损扩大","url":"https://stock-news.laohu8.com/highlight/detail?id=1130632456","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130632456?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:56","pubTimestamp":1754488617,"startTime":"0","endTime":"0","summary":"周三盘中，基因编辑技术公司Beam Therapeutics, Inc.股价大幅下跌5.08%，引发市场关注。这一显著跌幅与公司最新发布的第二季度财务报告密切相关。根据Beam Therapeutics发布的2025财年第二季度财报，公司业绩表现不佳。报告显示，2025年前六个月公司累计收入为1593.60万美元，较去年同期的1918.20万美元下降16.92%。分析人士指出，Beam Therapeutics的收入下滑和亏损扩大可能是导致股价大跌的主要原因。作为一家专注于开发精密基因药物的生物科技公司，投资者对其财务状况和研发进展高度敏感。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"1139618416","title":"异动解读 | Beam Therapeutics盘中大跌5.08%，Q2财报显示业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=1139618416","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139618416?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:56","pubTimestamp":1754488612,"startTime":"0","endTime":"0","summary":"生物科技公司Beam Therapeutics今日盘中股价大跌5.08%，引发市场关注。这一股价下跌主要受到公司最新发布的第二季度财报影响，财报显示公司业绩出现明显下滑。根据Beam Therapeutics发布的财报，2025财年前六个月公司累计收入为1593.60万美元，相比去年同期的1918.20万美元下降了16.92%。作为一家致力于开发精密基因药物的生物科技公司，Beam Therapeutics的研发投入可能是导致亏损扩大的主要原因之一。这份疲软的财报无疑打击了投资者信心，导致股价在交易时段出现大幅下跌。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BEAM"],"gpt_icon":0},{"id":"2549528354","title":"Beam Therapeutics Inc.盘中异动 早盘股价大涨5.06%报20.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549528354","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549528354?lang=zh_cn&edition=full","pubTime":"2025-07-08 21:37","pubTimestamp":1751981852,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日21时37分，Beam Therapeutics Inc.股票出现波动，股价快速上涨5.06%。截至发稿，该股报20.15美元/股，成交量29.487万股，换手率0.29%，振幅4.30%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家生物技术公司，致力于基于其专有的碱基编辑技术开发一类新的精准基因药物，为患有严重疾病的患者提供终身治愈方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213732953ae602&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708213732953ae602&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4505","BK4585","BK4588","BK4007","LENZ","BK4556","BK4139","BEAM","BK4611","BK4539"],"gpt_icon":0},{"id":"2518220291","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.20%报27.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220291?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:03","pubTimestamp":1741615383,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时03分，Beam Therapeutics Inc.股票出现异动，股价急速下跌5.20%。截至发稿，该股报27.00美元/股，成交量237.165万股，换手率2.83%，振幅3.72%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022030396403e21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4505","BK4611","BK4535","BK4585","BK4139","BK4556","BEAM"],"gpt_icon":0},{"id":"2517200169","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517200169","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517200169?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:32","pubTimestamp":1741271528,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时32分，Beam Therapeutics Inc.股票出现异动，股价大幅下挫5.09%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Plus Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Exicure, Inc.涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为953.51%、104.36%、48.88%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223208a2628fde&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","BEAM","BK4556","BK4588","BK4585","BK4535"],"gpt_icon":0},{"id":"2516670089","title":"Beam Therapeutics Inc.盘中异动 早盘急速下挫5.18%报23.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516670089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516670089?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:52","pubTimestamp":1741099972,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时52分，Beam Therapeutics Inc.股票出现异动，股价大幅跳水5.18%。截至发稿，该股报23.80美元/股，成交量20.2093万股，换手率0.24%，振幅2.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304225252abe7f683&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","BK4556","BK4535","BEAM","LENZ","BK4585","BK4588"],"gpt_icon":0},{"id":"2516619511","title":"数据：在PEPE、BEAM等代币上损失千万美元的巨鲸转向购买BTC和MKR","url":"https://stock-news.laohu8.com/highlight/detail?id=2516619511","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516619511?lang=zh_cn&edition=full","pubTime":"2025-03-04 12:42","pubTimestamp":1741063374,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896779398776512797","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4556","MKR.USD.CC","BK4585","BTCmain","BK4505","BK4139","BK4588","BK4601","BK4535","ETH","BTC.USD.HKCC","ETH.USD.HKCC","MKR.USD.HKCC","BTC","XBTmain","BEAM"],"gpt_icon":0},{"id":"2516663938","title":"Beam Therapeutics Inc.盘中异动 下午盘股价大跌5.13%报24.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516663938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516663938?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:28","pubTimestamp":1741033681,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时28分，Beam Therapeutics Inc.股票出现波动，股价大幅跳水5.13%。截至发稿，该股报24.99美元/股，成交量81.582万股，换手率0.97%，振幅6.47%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042801abe695f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4585","LENZ","BK4556","BK4139","BEAM","BK4505","BK4588"],"gpt_icon":0},{"id":"2516786035","title":"某巨鲸以1.17美元均价增持534万枚ONDO，曾投资PEPE及BEAM亏损超1400万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516786035","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516786035?lang=zh_cn&edition=full","pubTime":"2025-03-03 10:58","pubTimestamp":1740970730,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1896388254917955585","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4585","MKR.USD.HKCC","BEAM","BK4139","BK4505","BK4535","BK4588","BK4556"],"gpt_icon":0},{"id":"2516341379","title":"Beam Therapeutics Inc.2024财年实现净利润-3.77亿美元，同比减少183.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516341379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516341379?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:01","pubTimestamp":1740758461,"startTime":"0","endTime":"0","summary":"3月1日，Beam Therapeutics Inc.公布财报，公告显示公司2024财年净利润为-3.77亿美元，同比减少183.46%；其中营业收入为63.52百万美元，同比减少83.20%，每股基本收益为-4.58美元。从资产负债表来看，Beam Therapeutics Inc.总负债3.70亿美元，其中短期债务13.47百万美元，资产负债比为2.99，流动比率为4.83。机构评级：截至2025年3月1日，当前有14家机构对Beam Therapeutics Inc.目标价做出预测，其中目标均价为48.43美元，其中最低目标价为24.00美元，最高目标价为80.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000154a258185b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BEAM"],"gpt_icon":0},{"id":"2514186503","title":"Beam Therapeutics Inc.盘中异动 大幅下跌5.06%报28.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514186503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514186503?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:57","pubTimestamp":1740592630,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时57分，Beam Therapeutics Inc.股票出现异动，股价急速下挫5.06%。截至发稿，该股报28.33美元/股，成交量52.8583万股，换手率0.63%，振幅5.50%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270157109893d107&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4535","LENZ","BK4588","BK4585","BK4556","BK4139","BEAM"],"gpt_icon":0},{"id":"1166657736","title":"Beam Therapeutics 2024年第四季度GAAP每股收益$(1.09)好于预期$(1.18)，截至第四季度末持有8.507亿美元现金及有价证券，预计运营资金可支撑至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1166657736","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166657736?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:39","pubTimestamp":1740487180,"startTime":"0","endTime":"0","summary":"Beam Therapeutics报告季度每股亏损$，好于分析师预期的$，超出预期7.63%。相比去年同期盈余的$1.73，这一数字下降了163.01%。以上内容来自Benzinga Earnings专栏，原文如下：Beam $Therapeutics$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 7.63 percent. This is a 163.01 percent decrease over earnings of $1.73 per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BEAM","LENZ"],"gpt_icon":0},{"id":"2513899211","title":"Beam Therapeutics Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513899211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513899211?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:07","pubTimestamp":1740164828,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时07分，Beam Therapeutics Inc.股票出现异动，股价快速下跌5.07%。截至发稿，该股报31.46美元/股，成交量84.827万股，换手率1.02%，振幅7.39%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030709abd7e75f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222030709abd7e75f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BEAM","BK4585","BK4505","BK4556","LENZ","BK4139","BK4535"],"gpt_icon":0},{"id":"2512165058","title":"Beam Therapeutics Inc.盘中异动 早盘大幅上涨5.03%报34.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165058","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165058?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889142,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Beam Therapeutics Inc.股票出现波动，股价大幅拉升5.03%。截至发稿，该股报34.03美元/股，成交量5.7035万股，换手率0.07%，振幅1.33%。Beam Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.11%。Beam Therapeutics Inc.公司简介：Beam Therapeutics Inc 是一家从事基于其碱基编辑技术创造基因药物的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232229889fcc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502182232229889fcc1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","BK4139","BK4505","BK4535","BK4585","BEAM","BK4556"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beamtx.com","stockEarnings":[{"period":"1week","weight":0.0437},{"period":"1month","weight":0.0675},{"period":"3month","weight":0.038},{"period":"6month","weight":0.3672},{"period":"1year","weight":0.0683},{"period":"ytd","weight":0.0437}],"compareEarnings":[{"period":"1week","weight":0.0112},{"period":"1month","weight":0.0087},{"period":"3month","weight":0.0274},{"period":"6month","weight":0.1058},{"period":"1year","weight":0.1715},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Beam Therapeutics Inc.成立于2017年1月25日，是一家生物技术公司，致力于根据其专有的碱基编辑技术创建一类新型的精密基因药物，其愿景是为患有严重疾病的患者提供终身治疗疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.024305},{"month":2,"riseRate":0.6,"avgChangeRate":0.123426},{"month":3,"riseRate":0,"avgChangeRate":-0.205206},{"month":4,"riseRate":0.5,"avgChangeRate":-0.128126},{"month":5,"riseRate":0.5,"avgChangeRate":0.074807},{"month":6,"riseRate":0.833333,"avgChangeRate":0.150103},{"month":7,"riseRate":0.5,"avgChangeRate":0.084734},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.03415},{"month":9,"riseRate":0.333333,"avgChangeRate":0.012795},{"month":10,"riseRate":0.5,"avgChangeRate":0.022792},{"month":11,"riseRate":0.833333,"avgChangeRate":0.165588},{"month":12,"riseRate":0.5,"avgChangeRate":0.076029}],"exchange":"NASDAQ","name":"Beam Therapeutics, Inc.","nameEN":"Beam Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Beam Therapeutics, Inc.,BEAM,Beam Therapeutics, Inc.股票,Beam Therapeutics, Inc.股票老虎,Beam Therapeutics, Inc.股票老虎国际,Beam Therapeutics, Inc.行情,Beam Therapeutics, Inc.股票行情,Beam Therapeutics, Inc.股价,Beam Therapeutics, Inc.股市,Beam Therapeutics, Inc.股票价格,Beam Therapeutics, Inc.股票交易,Beam Therapeutics, Inc.股票购买,Beam Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Beam Therapeutics, Inc.(BEAM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Beam Therapeutics, Inc.(BEAM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}